(a)
Interpretation:
The type of enzyme regulation occurs in the pathway which stops at the first enzyme in the multistep process of the conversion of glucose to pyruvate should be determined.
Concept Introduction:
Enzyme:
- It is a protein or a molecule which can act as a catalyst for a biological reaction.
- Does not affect the equilibrium point of the reaction.
- Active site of the enzyme is the region where the reaction takes place.
- Enzyme’s activity can be specific which means the activity is limited to a certain substrate and a certain type of reaction and it is referred to as specificity of the enzyme.
Feedback control: The pathways which are dependent on a series of consecutive reactions in which the product of one reaction is the reactant for the next and these pathways are subjected to feedback control, which occurs when the result of a process feeds information back to affect the beginning process.
(b)
Interpretation:
The type of enzyme regulation occurs when Sarin covalently binds to acetylcholinesterase should be determined.
Concept Introduction:
Enzyme:
- It is a protein or a molecule which can act as a catalyst for a biological reaction.
- Does not affect the equilibrium point of the reaction.
- Active site of the enzyme is the region where the reaction takes place.
- Enzyme’s activity can be specific which means the activity is limited to a certain substrate and a certain type of reaction and it is referred to as specificity of the enzyme.
Reversible Competitive inhibition: It is a type of inhibition occurs when the inhibitor resembles very much to the substrate and thus prevents the substrate binding.
Reversible uncompetitive inhibition: It is a type of enzyme regulation in which an inhibitor binds reversibly to the enzyme-substrate complex and thereby blocking the binding of the second substrate to the binding site.
Irreversible competitive inhibition: It is a type of inhibition in which an inhibitor forms covalent bonds to the active site and thereby permanently blocking it.
(c)
Interpretation:
The type of enzyme regulation occurs when Lactase is not produced in the adult should be determined.
Concept Introduction:
Enzyme:
- It is a protein or a molecule which can act as a catalyst for a biological reaction.
- Does not affect the equilibrium point of the reaction.
- Active site of the enzyme is the region where the reaction takes place.
- Enzyme’s activity can be specific which means the activity is limited to a certain substrate and a certain type of reaction and it is referred to as specificity of the enzyme.
Enzyme inhibitors: The substance which slows or stops the action of an enzyme is called enzyme inhibitors.
It can be used as drugs and an example is AZT which is used to treat HIV.
Enzyme regulation by genetic control:
It is a type of control by which regulation of enzyme activity is done by the control of the synthesis of enzymes.
(d)
Interpretation:
The type of enzyme regulation occurs when the conversion of isocitrate to
Concept Introduction:
Enzyme:
- It is a protein or a molecule which can act as a catalyst for a biological reaction.
- Does not affect the equilibrium point of the reaction.
- Active site of the enzyme is the region where the reaction takes place.
- Enzyme’s activity can be specific which means the activity is limited to a certain substrate and a certain type of reaction and it is referred to as specificity of the enzyme.
Irreversible competitive inhibition: It is a type of inhibition in which an inhibitor forms covalent bonds to the active site and thereby permanently blocking it.
Want to see the full answer?
Check out a sample textbook solutionChapter 19 Solutions
Fundamentals of General, Organic, and Biological Chemistry (8th Edition)
- Why does it make metabolic sense for the same hormone signal to stimulate glycogenolysis and inhibit glycolysis in the liver while stimulating both glycogenolysis and glycolysis in muscles?arrow_forwardVon Gierke’s disease is a rare genetic disorder that results in a deficiency of glucose-6-phosphatase. Symptoms ketoacidosis, a buildup of glycogen in the liver, and lactate buildup. Why does this glycogen storage disease not affect the brain? a) The brain is able to still perform glycolysis effectively b) None of the above c) In the event of hypoglycemia, the brain is able to utilize other sources of energy to produce ATP d) The brain is able to metabolize lactate, which is present in high concetrations.arrow_forward64 An investigator is studying the mechanism of action of an insulin-sensitizing drug. The addition of the drug to cultured mouse hepatocytes is observed, and results show increased phosphorylation and inhibition of acetyl-CoA carboxylase Which of the following processes is most likely inhibited by this action of the drug? A) Fatty acid oxidation B) Fatty acid synthesis C) Glycogen synthesis D) Glycolysis E) Protein synthesisarrow_forward
- Glucose 6-phosphatase deficiency is a glycogen storage disease referred to as von Gierke disease. Which of the following symptoms would you NOT expect to see in patients with this disease? (A) severe fasting hypoglycemia (B) excess adipose triglyceride storage and low circulating levels of fatty acids (C) hyperammonemia (D) liver enlargement resulting from excess liver glycogen storage (E) lactic acidosis (F) goutarrow_forward(a) What amino acid, other than alanine, can be converted by transaminationto a gluconeogenic precursor? (b) Calculate the cost, in ATP equivalents, of converting two molecules of this amino acid to one molecule of glucose.arrow_forwardGlucosamine is a common compound that inhibits hexokinase action (the transfer of a phosphate group to glucose during glycolysis). A) Describe the consequences of glucosamine exposure on cellular respiration. B) Is glucosamine exposure fatal? Why or why not?arrow_forward
- If glucagon binds to the liver cell, what is the expected regulation of the bifunctional enzyme phosphofructokinase-2/fructose-2,6-bisphosphatase and how would the levels of fructose-2,6-bisphosphate be impacted?arrow_forwardWrite a one-sentence explanation for each of the following statements. (a) In liver, glucagon stimulates glycogen breakdown via cyclic AMP. Although one might expect glucagon also to stimulate catabolism of the glucose formed, glucagon inhibits glycolysis and stimulates glu- coneogenesis in liver. (b) An individual with a glucose-6-phosphatase deficiency suffers from chronic hypoglycemia. (c) The action of phosphorylase kinase simultaneously activates glycogen breakdown and inhibits glycogen synthesis. (d) The presence in liver of glucose-6-phosphatase is essential to the function of the liver in synthesizing glucose for use by other tissues.arrow_forwardName the following pathways:(a) Pathway for synthesis of glycogen(b) Pathway for release of glucose from glycogen(c) Pathway for synthesis of glucose from lactatearrow_forward
- Consider the following reaction. What is the consequence of the increase of cytosolic CAMP concentration during the fight-or-flight response? Adenylyl cyclase ATP CAMP PPi O a) The breakdown of glycogen into glucose 1-phosphate O b) The inhibition of glycolysis c) The inhibition of the phosphofructokinase d) The inhibition of the citric acid cycle e) The inhibition of the protein kinase Aarrow_forwardWrite a one-sentence explanation for each of the following statements.(a) In liver, glucagon stimulates glycogen breakdown via cAMP. Although you might expect glucagon to stimulate catabolism of the glucose formed as well, glucagon inhibits glycolysis and stimulates gluconeogenesis in liver.(b) An individual with a glucose-6-phosphatase deficiency suffers fromchronic hypoglycemia.(c) The action of phosphorylase kinase simultaneously activates glycogenbreakdown and inhibits glycogen synthesis.(d) The presence in liver of glucose-6-phosphatase is essential to the function of the liver in synthesizing glucose for use by other tissues.arrow_forwardWhich of the following statements about the pentose phosphate pathway (PPP) is true? (A) The purpose of the pentose phosphate pathway is to produce NADH for use in anabolic pathways and ribose 6-phosphate for nucleotide synthesis.(B) The oxidative arm of the PPP produces (2) NADPH per glucose 6-phosphate that enters the pathway. (C) Phosphopentose isomerase converts the ribose 5-phosphate made in the oxidative arm of the PPP into ribulose 5-phosphate that is used to form the ribose sugar of nucleotides.(D) The non-oxidative arm of the PPP interconverts between ribose 5-phosphate and a variety of intermediates of b-oxidation. (E) One of the functions of the PPP is to provide NADPH that inhibits glutathione reductase so that it cannot oxidatively damage RBCs.arrow_forward
- BiochemistryBiochemistryISBN:9781319114671Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.Publisher:W. H. FreemanLehninger Principles of BiochemistryBiochemistryISBN:9781464126116Author:David L. Nelson, Michael M. CoxPublisher:W. H. FreemanFundamentals of Biochemistry: Life at the Molecul...BiochemistryISBN:9781118918401Author:Donald Voet, Judith G. Voet, Charlotte W. PrattPublisher:WILEY
- BiochemistryBiochemistryISBN:9781305961135Author:Mary K. Campbell, Shawn O. Farrell, Owen M. McDougalPublisher:Cengage LearningBiochemistryBiochemistryISBN:9781305577206Author:Reginald H. Garrett, Charles M. GrishamPublisher:Cengage LearningFundamentals of General, Organic, and Biological ...BiochemistryISBN:9780134015187Author:John E. McMurry, David S. Ballantine, Carl A. Hoeger, Virginia E. PetersonPublisher:PEARSON